Publicacions
-
Rodríguez, JV; Prieto, A; Vilaprinyo, E; Bonet, M; Diez, M; Salud, A; Montal, R
Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis (vol 201, 104416, 2024)
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 202 104466-104466. .
-
Rodríguez, JV; Prieto, A; Vilaprinyo, E; Bonet, M; Diez, M; Salud, A; Montal, R
Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 201 104416-104416. .
-
O'Rourke, CJ; Salati, M; Rae, C; Carpino, G; Leslie, H; Pea, A; Prete, MG; Bonetti, LR; Amato, F; Montal, R; Upstill-Goddard, R; Nixon, C; Sanchon-Sanchez, P; Kunderfranco, P; Sia, D; Gaudio, E; Overi, D; Cascinu, S; Hogdall, D; Pugh, S; Domingo, E; Primrose, JN; Bridgewater, J; Spallanzani, A; Gelsomino, F; Llovet, JM; Calvisi, DF; Boulter, L; Caputo, F; Lleo, A; Jamieson, NB; Luppi, G; Dominici, M; Andersen, JB; Braconi, C
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Gut 73 496-508. .
-
Parisi, E; Hidalgo, I; Montal, R; Pallise, O; Tarragona, J; Sorolla, A; Novell, A; Campbell, K; Sorolla, MA; Casali, A; Salud, A
PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .
-
Ortiz-Barahona, V; Soler, M; Davalos, V; Garcia-Prieto, CA; Janin, M; Setien, F; Fernandez-Rebollo, I; Bech-Serra, JJ; de la Torre, C; Guil, S; Villanueva, A; Zhang, PH; Yang, L; Guarnacci, M; Schumann, U; Preiss, T; Balaseviciute, U; Montal, R; Llovet, JM; Esteller, M
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
MOLECULAR CANCER 22 83-83. .
-
Oronich, A; Pallise, O; Salud, A; Montal, R
Genomic alterations and targeted therapies in extrahepatic cholangiocarcinoma
Hepatoma Research 9 -. .
-
Kudo, M; Montal, R; Finn, RS; Castet, F; Ueshima, K; Nishida, N; Haber, PK; Hu, YY; Chiba, Y; Schwartz, M; Meyer, T; Lencioni, R; Llovet, JM
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies.
CLINICAL CANCER RESEARCH 28 3443-3451. .
-
Sorolla, MA; Hidalgo, I; Sorolla, A; Montal, R; Pallise, O; Salud, A; Parisi, E
Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities
Cancers 13 -. .
-
Haber PK; Puigvehí M; Castet F; Lourdusamy V; Montal R; Tabrizian P; Buckstein M; Kim E; Villanueva A; Schwartz M; Llovet JM
Evidence-based management of Hepatocelluar Carcinoma: Systematic review and meta-analysis of randomized controlled trials (2002-2020).
Gastroenterology 161 879-898. .
-
Parisi E; Sorolla A; Montal R; González-Resina R; Novell A; Salud A; Sorolla MA
Prognostic Factors Involved in the Epithelial-Mesenchymal Transition Process in Colorectal Cancer Have a Preponderant Role in Oxidative Stress: A Systematic Review and Meta-Analysis.
Cancers 12 1-28. .
Projectes
- Immunophenotyping of Cholangiocarcinoma using Liquid Biopsy
- OncoNeoVac, un nuevo enfoque inmunoterapéutico para el tratamiento del melanoma.
- BIOMARCADORES EN BIOPSIA LÍQUIDA DE COLANGIOCARCINOMA AVANZADO PARA UNA INMUNO-ONCOLOGÍA DE PRECISIÓN
- Biomarcadores de Respuesta a Inmunoterapia mediante la Inmunofenotipificación Exhaustiva del Adenocarcinoma Gástrico.
- CONTRATOS JUAN RODÉS
- AYUDA SEOM - JUAN RODÉS 2021
- Editing of TERT promoter mutations with CRISPR/Cas9 technology for the treatment of Hepatocellular carcinoma
- Inmuno-oncología de precisión para el Adenocarcinoma Gástrico.
- Inteligencia Artificial basada en Patología y Transcriptómica Espacial para la identificación de la clase Inflamada del Adenocarcinoma Gástrico y la predicción de respuesta a Inmunoterapia.
